@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix microRNA: . @prefix hgnc: . @prefix geneProductOf: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:31775; a microRNA: . sub:_2 occursIn: obo:CLO_0007365, species:9606; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject schem:Metribolone; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:Metribolone) -> m(HGNC:MIR338)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "In contrast, expression of several microRNAs was significantly changed (FDR < 5%) in androgen-sensitive LNCaP cells after the R1881 treatment (Supplementary Table S3). One microRNA, miR-338, was significantly up-regulated. The other microRNAs were down-regulated, including miR-126-5p, miR-146b, miR-219-5p, and all members of the miR181b-1, miR-181c, and miR-221 clusters."; prov:wasQuotedFrom pubmed:18676839 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:18676839; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:23.789+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }